MAY 16, 2017 7:32 PM PDT

On-the-Go T Cells Better Equipped to Kill Tumor Cells

WRITTEN BY: Kara Marker

The main idea behind immunotherapy as an anticancer approach is to equip the human immune system with the tools it needs to fight cancer on its own, and enhancing the body’s natural strategies is often an effective method. Recently, scientists from the Garvan Institute of Medical Research found another natural strategy to improve on: T cell migration from tumor to tumor.

Cells that have exited from a tumor (red) in a lymph node of a photoconvertible mouse model. Credit: Tatyana Chtanova

There are so many types of cancer that sometimes a cure or complete prevention plan seems beyond our reach. However, what the many types of cancer have in common is what almost always ultimately causes death in cancer patients: metastasis. If T cells can be be trained to follow the tumor even as it metastasizes to different tissues in the body, cancer, even late-stage cancer, wouldn’t seem so daunting.

"We know that T cells and other immune cells accumulate inside tumors, but until now we've known very little about what happens next. How does the environment within the tumor change the cells? Do they leave the tumor? Which types of immune cells leave? Where do they go, and why?" asked lead research Dr. Tatyana Chtanova.

Chtanova and the team from the Garvan Institute used a strategy called “photoconversion” to observe the movement of T cells during an anticancer attack. Mouse cells were labeled with a green fluorescent compound that makes them appear red when researchers shine light on a tumor, indicating which cells made the journey into the tumor and which did not.

"We saw immune cells leaving the tumour and moving into lymph nodes - and, importantly, we could see immune cells moving out of one tumour and into another, distant tumour,” Chtanova described.

Interestingly, the types of cells going in and the cells going out were different. T cells were more likely than other cells to leave a tumor and travel to either the lymph nodes or another tumor site, specifically CD8+ effector T cells. This makes sense, Chtanova says, because these T cell subtypes “promote tumor destruction.”

Their second observation is all the more promising: T cells leaving the tumor to travel somewhere else were more activated, with “stronger cytotoxic activity” compared to the cells that stayed put.

"Within the tumor, these T cells are acquiring knowledge about the cancer that helps them to seek and destroy tumor cells,” Chtanova explained. “It's possible that these T cells 'on patrol' are using their new-found knowledge to attack cancerous cells in the second tumor."

The next logical step is this: if effector T cells leaving the tumor to fight cancer elsewhere are better at killing tumor cells, there should be a way to maximize the number of T cells traveling to multiple destinations in the body.

The present study was published in the journal Proceedings of the National Academy of Sciences (PNAS).

Source: Garvan Institute of Medical Research

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
APR 22, 2020
Drug Discovery & Development
Only 3% of COVID-19 Antibody Tests Approved by FDA
APR 22, 2020
Only 3% of COVID-19 Antibody Tests Approved by FDA
So far, only 3% of at least 90 COVID-19 antibody tests in the US have been approved by the Food and Drug Administration ...
MAY 03, 2020
Microbiology
Understanding How Lyme Disease Persists in the Body
MAY 03, 2020
Understanding How Lyme Disease Persists in the Body
Lyme disease is a confounding illness that can be difficult to diagnose, and can cause a wide range of serious health pr ...
JUN 14, 2020
Microbiology
Amping Up Immunity to Respiratory Viruses by Targeting Memory T Cells in the Lungs
JUN 14, 2020
Amping Up Immunity to Respiratory Viruses by Targeting Memory T Cells in the Lungs
It's easier than thought to activate immune cells that reside in the lungs and are involved in long-term immunity. Image ...
JUN 23, 2020
Immunology
Nanosponges Mop up Viruses to Treat COVID Infections
JUN 23, 2020
Nanosponges Mop up Viruses to Treat COVID Infections
  Scientists have developed an experimental therapy for COVID-19 that uses coated nanoparticles to intercept SARS-C ...
JUL 14, 2020
Immunology
Itsy Bitsy Nanobodies to Defeat the Big Bad Coronavirus
JUL 14, 2020
Itsy Bitsy Nanobodies to Defeat the Big Bad Coronavirus
Scientists are working on developing an arsenal of nano-sized weapons in the war against COVID-19. These molecules, call ...
JUL 17, 2020
Immunology
More Potential Antibody Therapies for COVID Emerge
JUL 17, 2020
More Potential Antibody Therapies for COVID Emerge
When it comes to clinical countermeasures against COVID-19, one class of molecules stands out among the others: antibodi ...
Loading Comments...